Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy
Clinical Trial Grant
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Catalyst Pharmaceuticals, Inc.
Start Date
September 20, 2024
End Date
September 3, 2029
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Catalyst Pharmaceuticals, Inc.
Start Date
September 20, 2024
End Date
September 3, 2029